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ABSTRACT
International Journal of Exercise Science 13(4): 1448-1458, 2020. Incidence of obesity is increasing
worldwide which is deleterious to health due to its association with increased risk of cardiovascular disease,
diabetes, and some cancers. Completion of regular physical activity in individuals with obesity increases maximal
oxygen uptake (VO2max). However, whether individuals with obesity can exhibit ‘true’ VO2max is unresolved.
This study examined efficacy of verification testing (VER) to identify ‘true’ VO2max in 17 inactive women with
obesity (age, body fat, and VO2max = 37 ± 10 yr, 48.7 ± 3.5 %, and 19.4 ± 3.0 mL/kg/min, respectively). They
performed ramp exercise (RAMP) to volitional fatigue followed by VER at 105 percent peak power output (%PPO)
at baseline and after 3 and 6 wk of high intensity interval training. Results showed no difference in ramp and
verification-derived VO2max (1.99 ± 0.37 L/min vs. 1.98 ± 0.32 L/min, 2.00 ± 0.40 L/min vs. 2.04 ± 0.38 L/min, and
2.08 ± 0.34 L/min vs. 2.08 ± 0.32 L/min at 0, 3 and 6 wk of training), although in 40 % of VER tests, VO2max was
greater than the RAMP value. Overall, verification testing may be adopted as an additional approach to confirm
‘true’ VO2max attainment in obese women as ramp exercise frequently underestimates VO2max in this population.
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INTRODUCTION
Obesity is defined as excess body fat or a body mass index above 30 kg/m2 (6). In the United
States, there has been a marked increase in obesity, as 30 % of adults were obese in 2000 which
increased to 40 % in 2017 (7). Obesity reduces health status as it increases risk of cardiovascular
disease, diabetes, and some cancers (19). In addition, the economic costs of obesity are staggering
since $147 billion were spent in the treatment of obesity in 2008 (12).
Adults with obesity are recommended to complete a minimum of 150 min/wk of moderate
intensity continuous training to elicit various health benefits including improvements in
maximal oxygen uptake (VO2max), which benefits activities of daily life and reduces mortality
risk (5). Despite the benefits of regular physical activity, obese individuals’ participation in
habitual activity is low (31) which makes reversing the co-morbidities associated with obesity
challenging for clinicians.
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VO2max is assessed during progressive exercise to exhaustion (RAMP), and various primary
and secondary criteria are commonly used to verify incidence of ‘true’ VO2max (3, 20).
However, these criteria have been criticized as they do not distinguish between persons who do
and do not attain a ‘true’ VO2max (15). Poole et al. (27) reported that maximal respiratory
exchange ratio (RER > 1.10 or 1.15) occurs at intensities prior to attainment of VO2max. There
are over 30 separate criteria to confirm VO2max attainment using predicted maximal heart rate
(HR) (27), which diminishes the validity of this criterion. Recently, the verification test (VER)
performed subsequent to RAMP was developed, and data acquired from older adults (9), active
individuals (26, 30), inactive adults (2), and athletes (16, 20) show that this test yields similar
estimates of VO2max versus RAMP, hence confirming ‘true’ VO2max.
In 135 overweight or obese adults with VO2max between 27 – 42 mL/kg/min, Wood et al. (32)
investigated attainment of various VO2max criteria in response to treadmill RAMP exercise and
a subsequent verification test. Data showed similar maximal values of VO2 and HR between
tests. Sawyer et al. (29) showed that verification testing at 100 percent peak power output
(%PPO) elicited ‘true’ VO2max in adults with obesity, as mean values were similar between
protocols. However, many participants’ VER-derived VO2max was higher than the RAMP
value. Moreover, authors used a work rate equivalent to PPO for the verification test rather than
above PPO as recommended (21), which does not confirm that a higher intensity does not elicit
a higher VO2.
Recently, Barry et al. (5) emphasized the importance of increasing fitness rather than reducing
fatness in adults, as the former seems to elicit superior health-related benefits than the latter.
Moreover, Gaesser et al. (14) stated that increasing fitness rather than promoting weight loss
should be the primary goal of most exercise regimens due to the difficulty in promoting longterm weight loss in most adults. Enhancing cardiorespiratory fitness in populations including
the obese requires an accurate measure of fitness to monitor training-induced changes, and it is
plausible that an erroneous measure of fitness may cause inaccurate decisions regarding
subsequent health care.
This study examined use of verification testing to confirm VO2max attainment in inactive
women with obesity. We compared VO2max values between RAMP and VER which required
supramaximal work rates as previously recommended (20). It was hypothesized that mean
VO2max would not differ between protocols, but many participants would reveal higher
VO2max with VER versus RAMP. Identifying a ‘true’ VO2max is important in every individual
who completes exercise testing, as this value can be used to prescribe exercise training, assess
efficacy of exercise training, and classify health risks.
METHODS
Participants
Women who were insufficiently active (< 2 h/wk of moderate to vigorous activity in the
previous 12 mo) and obese (body mass index > 35 kg/m2) participated in this study. All met this
physical activity criterion, although some women engaged in infrequent physical activity;
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whereas, others performed none. At baseline, their age, body mass index, and percent body fat
were equal to 37 ± 10 yr, 39 ± 4 kg/m2, and 48.7 ± 3.6 %, respectively. They were recruited from
flyers placed on campus as well as word-of-mouth. All women were healthy non-smokers, were
not taking medications known to alter metabolism, and lacked joint pain. Participants
completed the Physical Activity Readiness Questionnaire (1) and a health history questionnaire
before initiating the study. Written informed consent was obtained from participants prior to
the study, and the protocol was approved by the University Institutional Review Board. This
research was carried out fully in accordance to the ethical standards of the International Journal
of Exercise Science (25). Data concerning changes in VO2max, body composition, and muscular
force in response to this intervention have already been published (8).
Protocol
Assessment of VO2max: Initially, height and body mass were determined using a balance scale
and stadiometer, and then body composition was measured using air displacement
plethysmography (BodPod, COSMED USA Inc., Chicago, IL). Participants performed RAMP
exercise on an electrically-braked cycle ergometer (Velotron DynaFit Pro, RacerMate, Seattle,
WA). Power output started at 40 W for 2 min and was increased by 20 W/min until exhaustion
which was identified by cadence < 50 rev/min. Gas exchange data were acquired every 15 s
with a metabolic cart (ParvoMedics TrueOne, Sandy, UT) which was calibrated pre-exercise
according to manufacturer’s recommendations. Change in VO2 at VO2max was identified as the
difference between the highest consecutive VO2 values during the last 60 s of exercise (29).
During exercise, HR was continually measured via telemetry (Polar Electro, Woodbury, NY).
PPO was identified as the work rate consequent with volitional fatigue. After a 10 min active
recovery at 20 W, women were told to increase their cadence, and VER ensued at 105 %PPO to
confirm incidence of ‘true’ VO2max. This test was stopped when pedal cadence dropped below
50 rev/min. Maximal oxygen uptake was determined from both tests as the mean of the two
highest consecutive values within the last four measurements. Data presented here are from a
total of 51 assessments of VO2max, which were acquired at baseline, during, and after cessation
of training.
High intensity interval training: Sessions were performed in the lab 2 d/wk on the same cycle
ergometer as well as 1 d/wk on their own, with at-home training following the structure of labbased training for that week. Each session was preceded by a 5 min warm up at 20 %PPO.
Training structure was implemented to cater to a very unfit population with likely negative
attitudes to exercise training. Consequently, it could not require a huge amount of time or be so
exhaustive that would potentially reduce compliance. Moreover, training structure changed
frequently to provide the women with a novel stimulus that may enhance their compliance to
training. During lab-based training, HR was continuously assessed using telemetry (Polar, Lake
Success, NY); whereas, at-home training intensity (> 85 %HRmax) was confirmed using a
downloadable monitor (Polar, Lake Success, NY).Training intensities were adjusted after
session 9 based on a second VO2max assessment. The training regimens are shown in Table 1.
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Table 1. Description of the high intensity interval training performed in the study.
Bout
Number of
Rest Duration Intensity (%
Warm Up
Traditional
Duration
Bouts
(seconds)
PPO)
(minutes)
(seconds)
Week 1
10
60
60
70
5
Week 2
10
60
60
75
5
Week 3
10
60
60
80
5
Week 4
10
60
60
75
5
Week 5
10
60
60
80
5
Week 6
10
60
60
85
5
Periodized
Week 1
10
60
60
70
5
Week 2
6
20
120
105
5
Week 3
7
120
60
60
5
Week 4
10
60
60
75
5
Week 5
6
20
120
110
5
Week 6
7
120
60
65
5

Total Time
(minutes)
25
25
25
25
25
25
25
19
26
25
19
26

Identifying individual differences in VO2max and HRmax between protocols: We used a typical
error score acquired from repeated testing of VO2max using the identical exercise protocol 3 (n
= 14) and 6 wk apart (n = 7) in young sedentary women (age and VO2max = 23 ± 2 yr and 29 ± 3
mL/kg/min) to ascertain individual differences in RAMP and VER-derived VO2max. The
typical error was equal to 0.03 and 0.06 L/min for ramp and verification testing, respectively.
Consequently, we used a conservative difference in VO2max between protocols < 0.06 L/min to
identify ‘true’ VO2max. Difference in HRmax between protocols of < 2 b/min (7) was used to
determine that the ramp-derived value was maximal.
Statistical Analysis
Data are expressed as mean ± SD and were analyzed using SPSS 24.0 (Armonk, NY). Paired ttest was used to compare maximal HR and gas exchange variables between RAMP and VER.
One-way analysis of variance with repeated measures was used to examine differences in gas
exchange variables across time (0, 3, and 6 wk). If a significant F ratio was obtained, Tukey’s
post hoc test was used to identify differences between means. The Pearson product moment
coefficient was used to examine pairwise associations between variables, and intraclass
correlation coefficients (ICC) were used to examine the reliability of VO2 and HR between
protocols. Significance was set at p < 0.05.

RESULTS
Differences in VO2max and HRmax between RAMP and VER: Table 2 shows differences in
VO2max and HRmax between protocols. Data revealed no difference in VO2max between RAMP
and VER at 0 (p = 0.90), 3 (p = 0.34), and 6 wk (p = 0.80) of training. Also, the absolute difference
in VO2max between protocols at 0 (-0.01 ± 0.14 L/min), 3 (0.04 ± 0.17 L/min), and 6 wk (0.01 ±
0.11 L/min) was insignificant (p = 0.61). Change in VO2 at VO2max was unchanged during the
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study (p = 0.06) and was equal to 0.08 ± 0.13, -0.01 ± 0.11, and -0.01 ± 0.08 L/min at 0, 3, and 6
wk. Verification duration increased during the study (p = 0.04) and was higher at 3 and 6 wk of
training versus baseline. Intraclass correlation coefficients were equal to 0.96, 0.95, and 0.97
between RAMP and VER-derived VO2max. Figure 1 demonstrates a positive and significant (r
= 0.92, p < 0.001) association between VO2max values from both protocols across all timepoints
of the study (n = 51). The mean difference was equal to 0.01 L/min across all tests, with limits
of agreement equal to -0.26 to 0.28 L/min, respectively (Figure 2).
Maximal HR was not different at any time point between RAMP and VER (p = 0.25, 0.46, and
0.41), respectively, and difference in HRmax was similar (p = 0.20) between RAMP and VER at
0 (-1.9 ± 5.7 b/min), 3 (1.4 ± 7.0 b/min), and 6 wk (-1.3 ± 5.1 b/min) of training. The ICC for
HRmax between protocols was equal to 0.97, 0.92, and 0.96, respectively.
Table 2. Maximal gas exchange data from ramp and verification testing in women with obesity (mean ± SD).
Parameter
Baseline
3 wk
6 wk
VO2maxramp (l/min)
1.99 ± 0.37
2.00 ± 0.40
2.08 ± 0.34a
VO2maxVER (L/min)
1.98 ± 0.32
2.04 ± 0.38
2.08 ± 0.32a
HRmaxramp (b/min)
177.3 ± 14.6
171.8 ± 15.8
175.2 ± 12.0
HRmaxVER (b/min)
175.8 ± 13.9
173.2 ± 12.1
174.1 ± 12.2
RERmaxramp
1.33 ± 0.08
1.24 ± 0.07
1.26 ± 0.06
RERmaxVER
1.17 ± 0.12*
1.13 ± 0.10*
1.14 ± 0.06*
VEmaxramp (L/min)
87.7 ± 18.7
81.3 ± 19.7
86.7 ± 16.1
VEmaxVER (L/min)
87.0 ± 17.0
82.2 ± 17.4
87.0 ± 16.6
DurationVER (min)
1.38 ± 0.27
1.60 ± 0.34a
1.54 ± 0.30a
a = p < 0.05 versus baseline; VER = verification test; HR = heart rate; RER = respiratory exchange ratio; *= p < 0.05
versus ramp within time; VE = ventilation

Differences in gas exchange data between RAMP and VER: No difference occurred in VEmax
between protocols (p > 0.76). Yet, RERmax was higher (p < 0.001) in response to RAMP versus
VER (Table 2).
Individual differences in VO2max and HRmax between RAMP and VER: Despite no mean
differences in VO2max between protocols, many participants ‘true’ VO2max was not attained
via RAMP. At 0, 3, and 6 wk, 5 (30 %), 9 (53 %), and 7 (41 %) women revealed a verification
VO2max value that was > 0.06 L/min higher than obtained from RAMP. Three women (mean
VO2max = 18.3 mL/kg/min) exhibited consistent underestimations of VO2max in response to
RAMP, as their verification-derived value was 0.09 ± 0.02 L/min (4.5 %) higher at 0, 3, and 6 wk
of training. Across all tests, differences in VO2max between RAMP and VER ranged from -0.45
– 0.35 L/min. There was no association between VO2max (r = -0.20, p = 0.15) or verification
duration (r = 0.19, p = 0.18) and the difference in VO2max between protocols.
Data show that 4 (23 %), 7 (41 %), and 5 (30 %) participants exhibited a difference in HRmax > 2
b/min in response to VER versus RAMP. This difference ranged from -9 – 18 b/min across all
tests.
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Figure 1. Association between VO2max achieved on the incremental trial compared to VO2max achieved on the
verification trial.
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Figure 2. Bland-Altman plot with mean VO2max on the x-axis and the difference between ramp and verificationderived VO2max on the y-axis. Solid line = mean difference between verification and ramp VO2max = 0.01 L/min;
dashed line = mean ± 1.96 SD.

DISCUSSION
Low VO2max is associated with enhanced morbidity and mortality (24) which is why improving
this outcome is a primary goal of many exercise regimens. Nevertheless, it is often difficult to
confirm ‘true’ VO2max using established criteria as they are unable to distinguish between
individuals who do and do not reveal a ‘true’ VO2max (2, 27). We tested the efficacy of repeated
verification testing in obese women with a VO2max almost 40 % below age-matched norms (18)
who performed chronic interval training (8). Data show that despite no difference in mean
VO2max or HRmax between protocols at any time point, a large amount of RAMP tests
underestimate VO2max which may warrant verification testing in populations with obesity
when a ‘true’ VO2max value is needed.
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Our data support others (9, 13, 16, 29) showing that at a group level, there is no difference in
VO2max between RAMP and VER, which suggests that the value acquired from ramp testing is
indeed maximal. Yet, VO2max is measured on an individual level to measure cardiorespiratory
fitness and in turn, classify mortality risk, prescribe exercise regimens, and monitor responses
to exercise training, so only comparing mean values is impractical. Our cutoff value acquired
from repeated maximal exercise testing in inactive women demonstrated that 40 % of RAMP
tests underestimated VO2max. A 2 % cutoff value was previously used (29) which did not appear
to be acquired from repeated testing, and results showed that 70 % of participants revealed a
higher VO2max in VER versus RAMP. If we used this less conservative criterion in our sample,
52 % of VER tests exhibit a higher VO2max (> 0.04 L/min) versus RAMP. Rather than utilizing
some arbitrary value, we recommend that authors develop and report typical error values for
both ramp and verification-derived VO2max measured in their own lab, as previously utilized
(15, 30), to better characterize individual differences in VO2max between protocols.
Murias et al. (23) reported that RAMP was able to confirm VO2max attainment in active young
(age and VO2max 25 ± 4 yr and 49 ± 8 mL/kg/min) and older men (age and VO2max = 65 ± 5 yr
and 31 ± 7 mL/kg/min), as data showed no difference in mean VO2max between RAMP and
verification testing at 85 and 105 %PPO. However, their study has a few methodological
differences versus ours. First, their participants had a VO2max that was 50 to > 100 % higher
than our population, and well above average for men this age (18). Previous work shows that
persons with lower fitness are more apt to show a significant underestimation of VO2max in
response to ramp testing than more fit individuals (4), so it is possible that their conclusions
stem from the high fitness level of their sample. It is plausible that persons with low
cardiorespiratory fitness terminate ramp exercise prematurely due to onset of leg pain,
breathlessness, or general discomfort which may elicit underestimation in VO2max, yet when
allowed to perform a subsequent verification test, they are more familiar with the effort required
and may actually reveal a ‘true’ VO2max. In addition, Jones et al. (17) stated that incremental
testing may augment oxygen kinetics in the subsequent verification test, leading to a higher VO2
value. Second, Murias et al. (23) only presented mean data and no individual data were
reported. Our results and others (2, 15, 29) show that many participants show higher VO2max
from verification testing compared to RAMP, despite no aggregate differences in VO2max.
Results from Misquita et al. (22) in 108 postmenopausal women (age, VO2max, and BMI = 60 ±
6 yr, 19 ± 3 mL/kg/min, and 33 ± 4 kg/m2) showed low incidence of a VO2 plateau as well as
attainment of secondary criteria including maximal HR (220 – age) and RER > 1.10. Their data
also indicated that women with a higher VO2max tended to attain these criteria versus those
with lower VO2max, which is supported by results acquired from active older adults (9).
Similarly, other data (10) reported low (< 60 %) attainment of VO2max criteria in obese women,
and recommended that alternative criteria be used to verify incidence of VO2max. All our
participants except one exhibited RER > 1.10 in all tests, but in only 9 of 51 tests (18 %) did they
attain the HRmax criterion equal to 10 b/min within 220 – age, which suggests that this is not
able to confirm maximal effort in this population.
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This study has a few limitations. First, VO2max was tested only once at each timepoint, and
recent data acquired in young individuals (11) show small but significant increases in VO2max
across repeated testing. Second, our data apply to healthy women with obesity and not those
with comorbidities including diabetes or cardiovascular disease who may be intolerant of
supramaximal exercise required in verification testing. Third, our cutoff value signifying a
meaningful difference in VO2max between protocols was developed from inactive women
whose VO2max is higher than that of our sample. However, its magnitude of approximately 3
% is similar to that reported in older adults (9), but lower than a value used in younger adults
(29). Further study is merited to identify test-retest reliability of verification testing in
individuals with obesity, as to our knowledge, this value is unknown.
In conclusion, our findings obtained in insufficiently active obese women undergoing
incremental exercise testing show that 40 % of tests reveal a higher VER-derived VO2max value,
which supports its implementation in this population as another criterion to confirm attainment
of VO2max, especially when monitoring changes in cardiorespiratory fitness acquired in
response to training. Verification testing completed at supramaximal workloads was welltolerated and did not cause any adverse events, so this test appears to be safe in obese women
with low cardiorespiratory fitness. However, the magnitude of difference in VO2max is small
(~0.7 mL/kg/min), so the clinical relevance of this finding is unknown and requires further
study.
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